Chris has over 20 years experience working at board level in global companies, to support major strategic and business model changes. This has included strategic developments in many areas of the oil, gas and petrochemical industry in different cultural environments, for clients including BP, Shell, BG, ADNOC, SNC Lavalin, Amec, and Weatherford.
Chris is a pharmacologist by background and was a founding partner of Bywater plc, the strategy consultancy who merged with Axon plc (a UK listed management consultancy with 2000 staff and operations in Europe, USA, Middle East and Far East). He was a Director at Axon until it’s acquisition by HCL.
Chris is a director of several UK listed & private companies and a regular contributor to the Oxford & Pepperdine International MBA programmes.